System Transmission

Top Signal

100#1 JOB

Activity

2172Ripe

+913 today

System

Livenow

Terminal Asset View

stockNASDAQ

MIRA

$1.21+1.68%

Mira Pharmaceuticals Inc

Ripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

76Ripe

Live Analysis Active

Company Mission

Mira Pharmaceuticals creates prescription medications for brain-related conditions including anxiety, dementia, and cognitive disorders. The company conducts scientific research to develop new drugs, then partners with larger pharmaceutical companies to test and potentially sell these treatments. They make money through research collaborations and would earn revenue from drug sales if their medications receive regulatory approval.

MIR

Industry Context

Biotechnology companies develop new medical treatments through scientific research. This industry experiences significant price swings when companies announce clinical trial results or receive regulatory approvals from agencies like the FDA.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

82Matrix

Market Momentum

46.5— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.5x— Normal Volume

Today's Change

1.68%— Live Performance

Social Frequency

Listening

Social Freq

0.3x

Normal Vol

X/Twitter Activity

0.3x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Price energy is building quickly for a potential move. Bullish alignment confirmed.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

18Velocity

Live Sync

Social Intelligence Pulse.

Our engine is currently indexing MIRA across global social channels to detect early sentiment shifts and technical alignment.

XActive

RedditActive

WebActive

Social Growth+3.0% vs 7D

Signal CoverageStandard Coverage

Signal Catalysts

Intelligence Narrative Connected

Updated 10:41 AM UTC

As-of 03-15-2026 10:25 UTC

Develops prescription drugs that treat brain disorders and makes money by selling these medicines to hospitals and pharmacies.

Weekly price swings are getting tighter near recent lows, suggesting a potential breakout move is building up.

Biotech sector volatility often increases during FDA decision periods, which could impact this company's stock movement.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...